Clinical Trial Update: A Study of AAVB-039 in Participants With Stargardt Disease (STGD1) [Phase 1, Phase 2]

View source ↗

Summary

AAVantgarde Bio Srl is conducting a Phase 1/2 study of AAVB-039 in participants with Stargardt disease (STGD1), and the trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stargardt Disease

Drugs mentioned

• AAVB-039

Snippet

Sponsor: AAVantgarde Bio Srl | Conditions: Stargardt Disease | Phase 1, Phase 2 | Status: RECRUITING